Renishaw PLC
09 July 2007
Renishaw plc
9 July 2007
Renishaw invests in D3 Technologies Limited
Renishaw is pleased to announce it has acquired a 75% interest in D3
Technologies Limited ('D3'), a company set up in collaboration with the
University of Strathclyde and others to exploit certain patents related to
Surface Enhanced Raman Spectroscopy ('SERS') and to develop SERS for molecular
diagnostics and trace detection.
Renishaw's investment in D3 will comprise cash of £1.85 million and
instrumentation, with a combined value of approximately £5m over the next 5
years.
Part of the investment has been used by D3 to purchase for £850,000 the business
and assets of the analytical business unit ('ABU') operated by Mesophotonics
Limited, a spin-out company from the University of Southampton. The ABU develops
and manufactures substrates used in SERS applications.
Combining the SERS technology and biochemistry expertise of the University of
Strathclyde with the Klarite(c) substrate technology of Mesophotonics ABU offers
a broad range of product opportunities to exploit in the growing healthcare
diagnostics and forensic markets.
As a leading supplier of Raman instrumentation Renishaw has a vested interest in
the furtherance of Raman spectroscopy and its applications into new and
developing markets.
Renishaw's principal business is the design, manufacture and sale of advanced
precision metrology and inspection equipment and analytical systems. Over 90% of
its sales are exported internationally through its world-wide network of
subsidiaries and distributors. Renishaw's sales for the financial year ended 30
June 2006 were £175.8m.
SIR DAVID R McMURTRY CBE RDI CEng FIMechE FREng
Chairman and Chief Executive
Renishaw plc
Enquiries: A C G Roberts 01453 524445
B R Taylor 01453 524445
Registered office: New Mills, Wotton-under-Edge, Gloucestershire. GL12 8JR
Telephone: 01453 524524
www.renishaw.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.